A Phase 1 Study of LY2523355 in Patients With Solid Cancer
Phase of Trial: Phase I
Latest Information Update: 07 Feb 2017
At a glance
- Drugs Litronesib (Primary)
- Indications Advanced breast cancer; Colorectal cancer; Gastric cancer; Non-small cell lung cancer; Oesophageal cancer; Ovarian cancer; Sarcoma; Small cell lung cancer; Solid tumours
- Focus Adverse reactions
- Sponsors Kyowa Hakko Kirin
- 23 Oct 2013 Results presented at the 25th AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics.
- 01 Jan 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 11 Jun 2012 Planned number of patients added to 12 as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History